Multiple sclerosis registry for adults
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study is a registry (a voluntary database) for people diagnosed with multiple sclerosis or a related first episode called clinically isolated syndrome. It helps researchers learn about how these conditions affect people over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Have been diagnosed with multiple sclerosis, or have clinically isolated syndrome
- Be at least 18 years old
- No other special requirements were listed
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study creates a registry for people with multiple sclerosis (MS) to track their health over time. The information gathered may help researchers better understand MS and improve care.
This is a registry study that collects health information from people with multiple sclerosis and related conditions. By joining, you help researchers better understand these diseases and improve future treatments.
This registry enrolls people with a confirmed diagnosis of multiple sclerosis (MS) who are age 18 or older and live in Switzerland (or receive their MS care there). It helps researchers better understand MS in the Swiss population and may improve future studies and care.
This study builds a patient-powered research network for people living with multiple sclerosis. It may help by gathering real-world information from patients to improve understanding of the disease over time.
This study follows people with multiple sclerosis to learn more about the disease and how it affects overall health. Researchers will collect information about your symptoms, treatments, and health outcomes over time to better understand MS and improve care.
This registry collects health information from adults with multiple sclerosis (MS) when they start an MS medicine. It may help researchers better understand treatment patterns and outcomes in real-world care.
Hear when a new Multiple sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.